PM360 Names Pharmafusion One of the Most Innovative Startups of 2019

Wednesday, December 18, 2019 Drug News
Email Print This Page Comment bookmark
Font : A-A+

Announcement caps transformative 2019 for industry veteran Jonathan Retano and his company's groundbreaking solutions.

EAST NORRITON, Pa., Dec. 17, 2019 /PRNewswire-PRWeb/ -- PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has named Pharmafusion LLC as one of the most innovative startups of 2019. This latest recognition caps off an impressive year for the company and its founder/CEO Jonathan Retano. Earlier in the year, Pharmafusion was featured as one of the "Top 10 Analytic Solution Providers" in pharma by Pharmatech Outlook Magazine. During the same timeframe Retano was featured in Global Business Reports "United States Biopharmaceuticals 2019" special issue highlighting U.S.-based industry innovators. These distinctions were followed by Acquisition INTL magazine's "2019 Global Excellence Awards 'Best Business Analytics Solutions Provider for Pharmaceuticals 2019 – Pennsylvania.'"

"It's tremendously gratifying to receive recognition for the work we've poured ourselves into," notes Retano. "For us, this is beyond what many would consider a job. We have a deep-seeded passion for what we do and continually strive to improve."

Retano describes the Pharmafusion360° platform as an asset comparable to Smart TV for pharmaceutical and biotech analytics, with multiple channels covering a vast array of datasets on a single integrated cloud-based platform. There are channels for marketing, field sales, managed-care, trade clinical, regulatory, business development, finance, and more. Once the datasets get integrated, new insights can be derived by combining previously disparate information. The platform cost-effectively provides easy-to-interpret visualizations and dashboards, empowering "C-suite" leaders and other users to discern real-world business insights while leveraging data for smarter and quicker decision-making.

"Our entire business model is built on having a complete, single integrated, turnkey solution and customizing our offering to meet the needs of our client partners," says Retano. "Having nearly 20 years' experience on the corporate side of the pharmaceutical industry, I understand the necessary information leadership teams rely on to successfully operate their companies."

From a broader perspective, as technology continues to advance at an ever-increasing pace, the pharmaceutical industry has traditionally been a relatively slow adapter of change. Increased competition within the industry forced that trend to begin shifting around 2017, and according to Retano this past year there has been a dramatic increase in the level of confidence industry leaders place on what data analytics and technology can do for a company's operations.

"An explosion of analytics is coming to the forefront of the current pharma commercialization conversation," says Wayne Eckerson, President of Eckerson Group. "I've been familiar with Jonathan and his award-winning, innovative approach for more than 10 years. He clearly is a pioneer and innovator in this arena. It's great to see the industry finally catching on."

According to one of Pharmafusion's more recent client partners, "Pharmafusion's craft data on tap, paired with Jonathan's expertise, provides insight to the ever-changing Pharma landscape. Pharmafusion is a valuable resource that has become an extension of our team." Noted another, their internal team was blown away by the data and the "stories" that data was telling them.

"What Pharmafusion has built for our organization is beyond what we could have imagined," states Pharmafusion client Ed Sadowski, R.Ph., Chief Operating Officer, Transition Patient Services. "It has quickly become our Bible. It has completely transformed our organization and allowed us to look at our

business in new ways that are translating into business growth. Connecting with Pharmafusion has dramatically moved the needle for our business."

For this most recent recognition, Pharmafusion was selected as part of PM360's "8th Annual Innovations Issue" published each December. This issue was established to serve as a guide to the year's most innovative Companies, Startups, Divisions, Products, Services, and Strategies from within the healthcare and life sciences industries. This comprehensive overview of the year's most innovative achievements in these six categories helps other companies in the industry find potential partners and offerings that can help them advance healthcare and life sciences.

Looking to the future, Retano's long-term vision for Pharmafusion is to continue garnering constructive input from industry experts and improve the platform to serve any new challenges in the industry such as artificial intelligence (AI) and machine learning. He also plans to enhance some of the analytic visuals ensuring that Pharmafusion360° becomes the gold standard in analytics for pharmaceutical companies of all sizes and at all stages of commercialization.

About Pharmafusion LLC Pharmafusion LLC, a privately held company located in East Norriton, Pennsylvania, is a one-stop-shop for pharmaceutical and biotech companies searching for comprehensive data analytics for a wide range of key business performance indicators. Supported by "in the trenches" experience on the corporate side of the industry, Pharmafusion provides client partners in marketing, finance, trade, managed-care, sales, clinical, business development, and regulatory with the information required to aid in successful commercialization efforts. The company's primary offering, Pharmafusion360°, goes beyond the breadth of what others in the industry provide, and does so with a quality of functionality and service that is unparalleled. Pharmafusion's current client base represents more than $50 billion in sales.

To learn more about Pharmafusion and its flagship offering, Pharmafusion360°, visit pharmafusion360.com, view an explainer video about the company at youtube.com/watch?v=2uImVN1Q4q4 or email Jonathan Retano at jon@pharmafusion360.com.

About PM360 PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment.

The journal's targeted and insightful editorial focuses on issues that directly impact critical decision making including: Planning and implementation of cutting-edge strategies, trends, the latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the "360" in the title signifies the span of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read.

By providing the full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game.

 

SOURCE Pharmafusion



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Premium Membership Benefits

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store